Related Experiment Video
Updated: Jul 8, 2026
Split-Ubiquitin Based Membrane Yeast Two-Hybrid (MYTH) System: A Powerful Tool For Identifying Protein-Protein Interactions
Published on: February 1, 2010
Identification of FMRP-associated mRNAs using yeast three-hybrid system
1National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Tsinghua University, Beijing, People's Republic of China.
Abstract:
Fragile X syndrome, one of the most common forms of inherited mental retardation, results from the absence of the fragile X mental retardation protein (FMRP), which is encoded by the fragile X mental retardation gene 1 (FMR1). FMRP is an RNA-binding protein involved in translational regulation of targeted mRNAs. Identification of targeted mRNAs associated with FMRP is important to understand the function of FMRP and the pathogenic basis of the fragile X syndrome. Employing a yeast three-hybrid system and a human fetal hippocampus cDNA library, we identified 22 candidate target mRNAs, and 18 of them were confirmed to be associated with FMRP in vitro by gel retardation. Some of these mRNAs code for structural proteins, enzymes or proteins involved in cellular processes, especially in the development and function of neural system. To further investigate the role of FMRP in regulating targeted gene expression, we analyzed the expression profile of TXNRD1, one of the candidate mRNAs, after knocking down the expression of endogenous FMRP by siRNA. The results showed that endogenous TXNRD1 translation increased along with depletion of FMRP, which suggested FMRP negatively regulates TXNRD1 translation.
Insights
Fragile X syndrome is caused by the absence of fragile X mental retardation protein (FMRP). This study identified FMRP-associated mRNAs, revealing FMRP negatively regulates TXNRD1 translation, offering insights into fragile X pathogenesis.
Area of Science:
- Neurogenetics
- Molecular Biology
- Biochemistry
Background:
- Fragile X syndrome, a common inherited intellectual disability, stems from the lack of fragile X mental retardation protein (FMRP).
- FMRP, an RNA-binding protein, regulates mRNA translation, making its target identification crucial for understanding its function and the syndrome's pathology.
Purpose of the Study:
- To identify novel messenger RNAs (mRNAs) targeted by FMRP.
- To elucidate the role of FMRP in regulating gene expression, particularly in neural development.
Main Methods:
- Utilized a yeast three-hybrid system and a human fetal hippocampus cDNA library to screen for FMRP-interacting mRNAs.
- Validated mRNA-protein interactions using gel retardation assays.
- Investigated the translational regulation of TXNRD1 by FMRP using siRNA-mediated knockdown of FMRP.
Main Results:
- Identified 22 candidate FMRP-target mRNAs, with 18 confirmed through in vitro assays.
- Discovered that some identified mRNAs encode proteins vital for neural system development and function.
- Demonstrated that depletion of FMRP leads to increased translation of TXNRD1, indicating negative regulation.
Conclusions:
- Established a set of FMRP-associated mRNAs, providing new targets for studying FMRP function.
- Provided evidence for FMRP's role as a negative regulator of TXNRD1 translation.
- The findings contribute to understanding the molecular mechanisms underlying fragile X syndrome.
